Updated Efficacy and Safety of Entrectinib in Patients (pts) with Locally Advanced/metastatic NTRK Fusion-Positive (fp) Non-Small Cell Lung Cancer (NSCLC).
JOURNAL OF CLINICAL ONCOLOGY（2023）
Key words
Treatment Guidelines
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined